Apollomics (APLM) Equity Average (2021 - 2025)
Apollomics (APLM) reported Equity Average of $19.0 million for Q4 2025, up 105.76% quarter-over-quarter from -$330.5 million in Q4 2022.
Apollomics (APLM) Equity Average (2021 - 2025) Analysis & Trends
Apollomics (APLM) has 3 years of Equity Average data on file, last reported at $19.0 million in Q4 2025.
- Equity Average for Q4 2025 came in at $19.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $19.0 million (changed N/A YoY), and the FY2025 annual result was $838000.0, down 96.36% from the prior year.
- Equity Average climbed to $19.0 million in Q4 2025 per APLM's latest filing, from -$330.5 million in the prior quarter.
- Over five years, Equity Average peaked at $19.0 million in Q4 2025 and troughed at -$330.5 million in Q4 2022.
- A 3-year average of -$160.6 million and a median of -$170.4 million in 2021 frame the typical range for Equity Average.
- On a YoY basis, Equity Average climbed as much as 93.95% in 2022 and fell as far as 93.95% in 2022.
- A 3-year view of Equity Average shows it stood at -$170.4 million in 2021, then slumped by 93.95% to -$330.5 million in 2022, then surged by 105.76% to $19.0 million in 2025.
- Business Quant data shows APLM's Equity Average at $19.0 million in Q4 2025, -$330.5 million in Q4 2022, and -$170.4 million in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 21.35 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 516.41 Mn |
| 10 | Apollomics | 294.00 Mn | 294.00 Mn | - | 19.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.02 Mn |
| Dec 31, 2022 | -330.49 Mn |
| Dec 31, 2021 | -170.40 Mn |